Terms: = Uterine cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257
661 results:
1. Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer.
Chen D; Cai B; Zhu Y; Ma Y; Yu X; Xiong J; Shen J; Tie W; Zhang Y; Guo F
Clin Epigenetics; 2024 Apr; 16(1):51. PubMed ID: 38576048
[TBL] [Abstract] [Full Text] [Related]
2. Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance and migration of cervical carcinoma cells.
Krishnamoorthy S; Sabanayagam R; Periyasamy L; Muruganantham B; Muthusami S
Med Oncol; 2024 Mar; 41(4):89. PubMed ID: 38520625
[TBL] [Abstract] [Full Text] [Related]
3. A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma.
Sun Y; Zhang K; Wang T; Zhao S; Gao C; Xue F; Wang Y
Sci Rep; 2024 Mar; 14(1):6134. PubMed ID: 38480789
[TBL] [Abstract] [Full Text] [Related]
4. Mitofusin-2 enhances cervical cancer progression through Wnt/β-catenin signaling.
Ahn SY
BMB Rep; 2024 Apr; 57(4):194-199. PubMed ID: 38449303
[TBL] [Abstract] [Full Text] [Related]
5. TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy.
Ren J; Chen X; Li J; Zan Y; Wang S; Tan Y; Ding Y
Epigenetics; 2024 Dec; 19(1):2323751. PubMed ID: 38431880
[TBL] [Abstract] [Full Text] [Related]
6. Elevated INHBA Promotes Tumor Progression of Cervical cancer.
Wu Z; Chen J; Yang L; Sun K; Jiang Q; Dong F; Lu W; Chen R; Chen Y
Technol Cancer Res Treat; 2024; 23():15330338241234798. PubMed ID: 38419562
[No Abstract] [Full Text] [Related]
7. Investigation of in-vitro Anti-cancer and Apoptotic Potential of Garlic-Derived Nanovesicles against Prostate and Cervical cancer Cell Lines.
Sharma V; Sinha ES; Singh J
Asian Pac J Cancer Prev; 2024 Feb; 25(2):575-585. PubMed ID: 38415544
[TBL] [Abstract] [Full Text] [Related]
8. Twist-1 Stimulates the Malignant Behaviors of Hydatidiform Mole via the PI3K/AKT Pathway.
Zhang C; Song Y; Yin Y; Hou H; Ge Z
Discov Med; 2024 Feb; 36(181):286-293. PubMed ID: 38409834
[TBL] [Abstract] [Full Text] [Related]
9. Atractylodes macrocephala III suppresses emt in cervical cancer by regulating IGF2BP3 through ETV5.
Wang M; Meng J; Wang H; Hu H; Hong Y
J Cell Mol Med; 2024 Feb; 28(4):e18081. PubMed ID: 38358034
[TBL] [Abstract] [Full Text] [Related]
10. The m6A methyltransferase RBM15 affects tumor cell stemness and progression of cervical cancer by regulating the stability of lncRNA HEIH.
Quan Y; Zhou M; Li J; Yang Y; Guo J; Tang T; Liu P
Exp Cell Res; 2024 Mar; 436(2):113924. PubMed ID: 38280435
[TBL] [Abstract] [Full Text] [Related]
11. FKBP38 suppresses endometrial cancer cell proliferation and metastasis by inhibiting the mTOR pathway.
Yan Y; Wang S; Zhang Z; Tang M; Zhao AZ; Li Z; Wu X; Li F
Arch Biochem Biophys; 2024 Feb; 752():109891. PubMed ID: 38218360
[TBL] [Abstract] [Full Text] [Related]
12. KLF5 inhibits the migration and invasion in cervical cancer cell lines by regulating SNAI1.
Qu X; Xu C; Yang W; Li Q; Tu S; Gao C
Cancer Biomark; 2024; 39(3):231-243. PubMed ID: 38217587
[TBL] [Abstract] [Full Text] [Related]
13. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
Zhang J; Yu X; Guo Y; Wang D
Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
[TBL] [Abstract] [Full Text] [Related]
14. Transcriptional factor CCAAT enhancer binding protein beta inhibits epithelial-mesenchymal transition in cervical cancer via regulating attractin-like 1.
Fang M; Zhou Y; Li Z; Li X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):1-7. PubMed ID: 38158696
[TBL] [Abstract] [Full Text] [Related]
15. cancer susceptibility 18 positively regulates NUAK Family Kinase 1 expression to promote migration and invasion via sponging of miR-5586-5p in cervical cancer cells.
Wang J; Zhang B; Gong S; Liu Y; Yi L; Long Y
Int J Immunopathol Pharmacol; 2023; 37():3946320231223310. PubMed ID: 38131232
[TBL] [Abstract] [Full Text] [Related]
16. Exploring the significance of tumor volume in endometrial cancer: Clinical pathological features, prognosis, and adjuvant therapies.
Fan Z; Sun X; Han X; Sun C; Huang D
Medicine (Baltimore); 2023 Dec; 102(50):e36442. PubMed ID: 38115321
[TBL] [Abstract] [Full Text] [Related]
17. Leptin secreted by adipocytes promotes emt transition and endometrial cancer progression via the JAK2/STAT3 signalling pathway.
Shen L; Zhang C; Cui K; Liang X; Zhu G; Hong L
Adipocyte; 2024 Dec; 13(1):2293273. PubMed ID: 38090745
[TBL] [Abstract] [Full Text] [Related]
18. SNHG3/WISP2 Axis Promotes Hela Cell Migration and Invasion
Xu D; Feng H; Ren Z; Li X; Jiang C; Chen Y; Liu L; Chen W; Cui Z; Cang S
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):744-753. PubMed ID: 38035707
[TBL] [Abstract] [Full Text] [Related]
19. Tumor-infiltrating immune cell score as an independent prognostic predictor for endometrial carcinoma: Insights from a comprehensive analysis of the immune landscape.
Zhang L; Zhu Q; Zhao Q; Lin X; Song H; Liu H; Zhu G; Lu S; Cao B
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1939. PubMed ID: 38017652
[TBL] [Abstract] [Full Text] [Related]
20. LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/β-catenin signaling pathway and emt in cervical cancer.
Cheng Z; Wang H; Yang Z; Li J; Chen X
BMC Cancer; 2023 Nov; 23(1):1128. PubMed ID: 37986152
[TBL] [Abstract] [Full Text] [Related]
[Next]
